Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST

Abstract In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project (www.nanotest-fp7.eu) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed.

[1]  Maria Dusinska,et al.  Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.

[2]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[3]  David B Warheit,et al.  How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Maria Dusinska,et al.  Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents , 2015, Nanotoxicology.

[5]  P. Niedermann,et al.  Transfer of ultrasmall iron oxide nanoparticles from human brain-derived endothelial cells to human glioblastoma cells. , 2013, ACS applied materials & interfaces.

[6]  Maria Dusinska,et al.  Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.

[7]  H. M. Nielsen,et al.  In vitro placental model optimization for nanoparticle transport studies , 2012, International journal of nanomedicine.

[8]  H. Karlsson,et al.  The comet assay in nanotoxicology research , 2010, Analytical and bioanalytical chemistry.

[9]  Sean Callanan,et al.  Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  L. Medina-Kauwe,et al.  Erratum: Chemotherapy targeting by DNA capture in viral protein particles (Nanomedicine (2012) 7:3 (335-352)) , 2012 .

[11]  Maria Dusinska,et al.  Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.

[12]  K. Wittmaack,et al.  Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. , 2011, ACS nano.

[13]  Sonja Boland,et al.  Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells , 2010, Particle and Fibre Toxicology.

[14]  Iseult Lynch,et al.  Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.

[15]  Maria Dusinska,et al.  Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.

[16]  M. Dusinska,et al.  Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. , 2012, Mutation research.

[17]  David P. Whistler,et al.  Chapter 11 , 2003, Aristotle's De Motu Animalium.

[18]  S. Retterer,et al.  Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. , 2013, Nanoscale.

[19]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[20]  Maria Dusinska,et al.  Toxicological aspects for nanomaterial in humans. , 2013, Methods in molecular biology.

[21]  J. Castell,et al.  Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  Maria Dusinska,et al.  Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles , 2015, Nanotoxicology.

[23]  Katsuhide Fujita,et al.  Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  M. Saunders,et al.  The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST , 2015, Nanotoxicology.

[25]  L. Juillerat-Jeanneret,et al.  Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles , 2014, International journal of nanomedicine.

[26]  Pratim Biswas,et al.  Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies , 2009 .

[27]  Sonja Boland,et al.  Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells , 2015, Nanotoxicology.

[28]  Martin Hassellöv,et al.  Analysis and Characterization of Manufactured Nanoparticles in Aquatic Environments , 2009 .

[29]  Andrew D. Maynard,et al.  Nanotoxicology: Laying a Firm Foundation for Sustainable Nanotechnologies , 2007 .

[30]  Michael T. Postek,et al.  Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities , 2012, Nanotoxicology.

[31]  P. Papazafiri,et al.  Computational modeling as part of alternative testing strategies in the respiratory and cardiovascular systems: Inhaled nanoparticle dose modeling based on representative aerosol measurements and corresponding toxicological analysis , 2015, Nanotoxicology.

[32]  Teresa F. Fernandes,et al.  Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far? , 2012, Ecotoxicology.

[33]  Andrew P Worth,et al.  A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles , 2011, Nanotoxicology.

[34]  Stephen M. Roberts,et al.  Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies , 2007 .

[35]  Iseult Lynch,et al.  Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Mark R. Wiesner,et al.  Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendations , 2011, Nanotoxicology.

[37]  G. Pojana,et al.  Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles , 2015, Nanotoxicology.

[38]  Antonio Marcomini,et al.  Effect-oriented physicochemical characterization of nanomaterials , 2007 .

[39]  Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials  , 2012, OECD Series on the Safety of Manufactured Nanomaterials and other Advanced Materials.

[40]  Kenneth A Dawson,et al.  A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. , 2011, Nanoscale.

[41]  R. Janzer,et al.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines , 1992, In Vitro Cellular & Developmental Biology - Animal.

[42]  L. Juillerat-Jeanneret,et al.  Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles , 2012, Cell Biology and Toxicology.

[43]  Lucienne Juillerat-Jeanneret,et al.  Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. , 2012, Nanomedicine.

[44]  P. Boor,et al.  Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats , 2014, Nanotoxicology.

[45]  L. Juillerat-Jeanneret,et al.  Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells , 2012, International journal of nanomedicine.

[46]  Maria Dusinska,et al.  Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging , 2015, Nanotoxicology.

[47]  Maria Dusinska,et al.  Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project , 2015, Nanotoxicology.

[48]  G. Daston,et al.  Toxicology of nanoparticles. , 2012, Advanced drug delivery reviews.

[49]  Ying Liu,et al.  Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. , 2013, Small.

[50]  Iseult Lynch,et al.  Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices , 2011, Nanotoxicology.

[51]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[52]  Andrew P. Worth,et al.  A rule for designing safer nanomaterials: do not interfere with the cellular redox equilibrium , 2015, Nanotoxicology.

[53]  Alexandra Kroll,et al.  Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.

[54]  J. Castillo,et al.  Critical considerations for the determination of nanoparticle number concentrations, size and number size distributions by single particle ICP-MS , 2013 .

[55]  Agnes G Oomen,et al.  What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.

[56]  M. Saunders,et al.  Critical Evaluation of Toxicity Tests , 2012 .

[57]  L. Knudsen,et al.  Kinetics of silica nanoparticles in the human placenta , 2015, Nanotoxicology.

[58]  G. Pojana,et al.  Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model , 2015, Nanotoxicology.

[59]  Lucienne Juillerat-Jeanneret,et al.  Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. , 2012, The Biochemical journal.

[60]  Margaret Saunders,et al.  Transplacental transport of nanomaterials. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[61]  Iseult Lynch,et al.  Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. , 2011, Nanomedicine.

[62]  Maria Dusinska,et al.  Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.